YD Bio Limited Ordinary SharesYDES

$2.42-0.10 (-3.97%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$8M

Micro-cap

-75%

2025 — today

10-Year Price

-75%

2025 — today

52-Week Range

$2.42$23.11

Current $2.42· 0%

Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.

Valuation in context

P/E ratio

-2.4

N/A

Not meaningful — company is unprofitable

P/B ratio

-0.5

N/A

Not meaningful — company is unprofitable

FCF Yield

-14.3%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when YDES is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.